[email protected]
On Twitter @mitchelzoler
© Frontline Medical Communications 2018-2021. Reprinted with permission, all rights reserved.
Converge Coverage
Atrial fibrillation blunts beta-blockers for HFrEF
AT HEART FAILURE 2017
Related Articles
Comparing Efficacy and Safety Between Patients with AF Taking DOACs or Warfarin After a DOAC Failure
June 11, 2017
CLINICAL QUESTION: Is warfarin better as a second-line anticoagulant than another direct oral anticoagulant (DOAC) in patients with atrial-fibrillation-induced ischemic strokes after failure of a...
Beta-Blockers Didn’t Reduce Mortality After Acute MI in Patients with Preserved Ejection Fraction
June 11, 2017
CLINICAL QUESTION: Do beta-blockers still reduce mortality after acute myocardial infarction (MI) in the modern era of faster and better reperfusion strategies? BACKGROUND: Beta-blockers have...
Anticoagulation Safety in Patients with Cirrhosis and AF
June 11, 2017
CLINICAL QUESTION: Do patients with cirrhosis and AF who are treated with anticoagulation have increased adverse safety events compared with patients with cirrhosis and AF who are not treated with...
Coding Corner: Type 1 MI, Type 2 MI, or Non-Ischemic Myocardial Injury
June 11, 2017
An 82-year-old female with a history of hypertension and stage 3 chronic kidney disease (CKD) was admitted with fever, hypotension, and confusion. The workup revealed Escherichia coli bacteremia due...